Record current issueAssembly Series

Gargoyle

  -  Faculty Experts


  -  News by Topic

  -  News by School


Search News & Info


WUSTL in the News
  - Powered by Google


WUSTL Home

Public Affairs Home

News
Releases

University News

Medical News

Sports News

Radio Service

Tip Sheets

Business, Law & Econ

Culture & Living

Science & Technology
Media Resources
Contact Information

TV/Radio Studio

Visiting Our Campuses

Campus Images

Sports photography
Commercial Filming
   and Photography


Commercial Use of
   Names and Symbols

Domain Name policy
WUSTL Information
Record (newspaper)

Campus Calendars

WUSTL News Summary

Publications Online

Facts, Guides & Maps


Washington University in St. Louis News & Information > Faculty Experts at Washington University in St. Louis >

Michael J. Welch

Professor of radiology

Expertise: PET, nuclear medicine, synthetic chemistry, oncology, imaging agents, radioisotopes, radionuclides

Bio: Welch, an expert in synthetic chemistry, has been a leader for more than 30 years in the development of synthetic imaging agents that have allowed doctors to use positron emission tomography (PET) to diagnose an increasingly wide variety of disorders. He is also head of the Radiochemistry Institute at the Mallinckrodt Institute of Radiology. Welch is the current principal investigator of Washington University's longest continuously renewed NIH grant, "Cyclotron Produced Isotopes in Biology and Medicine," now in its 45th year. The grant incarnation of the grant is dedicated to the development of new imaging agents that can help scientists better understand and diagnose the heart. The same grant supplied the funding that allowed WUSTL researcher Michel Ter-Pogossian to lead the development of the first PET scanner at the School of Medicine in the 1970s. Welch succeeded Ter-Pogossian as principal investigator in 1984.

WUSTL Contact Information:

Education:
  • Ph.D. at University of London
  • M.A. at Cambridge University
  • B.A. at Cambridge University


News Stories & Tip Sheets:

Showing 1 Stories.
Changing the way we see cancer

Advanced imaging systems offer faster, safer options for treatment of cancer

May 8, 2007 --
Joseph Culver, left, and Michael Welch examine a state-of-the-art diffuse optical tomography system, which allows researchers to visualize tumors without the use of radiation.
Joseph Culver, left, and Michael Welch examine a state-of-the-art diffuse optical tomography system, which allows researchers to visualize tumors without the use of radiation.
Using a wide range of imaging techniques to visualize cancer in the body, radiology investigators at the Siteman Cancer Center at Barnes-Jewish Hospital and Washington University School of Medicine are expanding the boundaries of cancer detection, treatment and research. The strength of their efforts has received national recognition. For several years, Mallinckrodt Institute of Radiology at Washington University School of Medicine has ranked among the top three imaging programs in the United States in research grants received by the National Institutes of Health (NIH).



Showing 1 Stories.

Related Information
Media Assistance:

Michael Purdy
Senior Medical Sciences Writer
purdym@wustl.edu

(314) 286-0122
Related Groups:

Schools:
School of Medicine

Departments:
Chemistry
Developmental Biology
Radiology

- View All Groups

Related Topics:
Chemistry
Medical Science
Science & Technology

- View All Topics

Revised:

Tuesday, Aug. 9, 2005


  Email this page

  Print ready page


News & Information  |   Medical News  |   Office of Public Affairs  |   WUSTL Home

Please contact us and let us know how we can assist you.
Technical problems with this Web site? Email questions or comments.
Please review the WUSTL News & Information copyright/privacy policy.